T11	Effect 72 114	increased risk of intracerebral hemorrhage
T13	Treatment 33 41;158 198	warfarin intravenous tissue plasminogen activator
T12	Subject 118 147;214 257	patients with ischemic stroke with an international normalized ratio <1.7
T15	Sub-Disorder 132 147	ischemic stroke
T9	Speculation_cue 46 86	may be associated with an increased risk
T16	Subject 158 198	intravenous tissue plasminogen activator
T17	Drug 33 41	warfarin
T19	Drug 159 198	ntravenous tissue plasminogen activator
